Latest filing published 14 Nov 2022 for CRESCENT BIOPHARMA, INC., €52k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -18.2%Entry US$170.00 · Close at T+365 US$139.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John L. Magnani: trading record in brief
John L. Magnani is a declared insider of Crescent Biopharma, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 15 January 2014 and 11 November 2022, the trades on record add up to 11 filings.
The open-market side counts 1 purchase for €52k alongside 4 sales for €307k. The net balance comes to €255k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 4 option exercises. 2022 to date brings 1 purchase and 1 sale.
Most recently, on 14 November 2022, the filings show an open-market purchase worth €52k in Crescent Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John L. Magnani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,045 shares@ US$1.1794.1% of flowCommon StockSEC:0001209191-22-056573:0Canonical exit: 9 Feb 2023 (T+90)
- 3,227 shares@ US$1.095.9% of flowCommon StockSEC:0001209191-22-017977:0
- 34,500 shares0Common StockSEC:0001209191-21-004840:0
- 106,983 shares@ US$1.1218.7% of flowCommon StockSEC:0001209191-20-002098:0
- 106,984 shares@ US$1.1218.8% of flowCommon StockSEC:0001209191-19-061782:0
- 14,200 shares@ US$14.0129.9% of flowCommon StockSEC:0001209191-18-055586:0
- 7,273 shares@ US$14.0015.4% of flowCommon StockSEC:0001209191-18-055586:1
- 3,527 shares@ US$14.027.5% of flowCommon StockSEC:0001209191-18-055586:2
- 1,491 shares@ US$0.330.1% of flowCommon StockSEC:0001209191-18-033068:0
- 8,928 shares@ US$1.121.6% of flowCommon StockSEC:0001209191-17-031515:0
- 9,969 sharesCommon StockSEC:0001209191-14-003340:0
11 of 11 declarations
